Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin.

Jianglan LongQiushi FangZhe ShiZenghui MiaoDan Yan

Published in: Diabetes, obesity & metabolism (2024)

The IBP composed of nine biomarkers can be used to predict the response of T2D patients to metformin, enabling clinicians to start a combined medication strategy as soon as possible if T2D patients do not respond to metformin.

Keyphrases

end stage renal disease
type diabetes
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
cardiovascular disease
emergency department
palliative care
adipose tissue
patient reported outcomes
insulin resistance
drug induced